VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Age 65 - 79                                        │ Age 65 - 79                                        │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of coronary artery disease (MI/heart       │ History of coronary artery disease (MI/heart       │     100 │
│ attack, stroke, heart failure, or peripheral       │ attack, stroke, heart failure, or peripheral       │         │
│ artery disease)                                    │ artery disease)                                    │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Cancer, with no active treatment in the last year  │ Cancer, with no active treatment in the last year  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Any tobacco or nicotine product use in the past    │ Any tobacco or nicotine product use in the past    │     100 │
│ year                                               │ year                                               │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Self-reported severe difficulty or inability to    │ Self-reported severe difficulty or inability to    │     100 │
│ walk 400m or climb 10 steps (from Q 2 and 19 on    │ walk 400m or climb 10 steps (from Q 2 and 19 on    │         │
│ PAT-D)                                             │ PAT-D)                                             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Self-reported difficulty or inability to perform   │ Self-reported difficulty or inability to perform   │     100 │
│ basic ADL functions (from Q 10, 13, 14, 16 on      │ basic ADL functions (from Q 10, 13, 14, 16 on      │         │
│ PAT-D)                                             │ PAT-D)                                             │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Cancer requiring treatment in past year (except    │ Cancer requiring treatment in past year (except    │     100 │
│ skin)                                              │ skin)                                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Parkinson's or other neurological disease          │ Parkinson's or other neurological disease          │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Chronic liver disease or cirrhosis                 │ Chronic liver disease or cirrhosis                 │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ End stage renal disease or on dialysis             │ End stage renal disease or on dialysis             │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Rheumatic conditions (Rheumatoid arthritis, lupus, │ Rheumatic conditions (Rheumatoid arthritis, lupus, │     100 │
│ and any other autoimmune disease the -PI deems     │ and any other autoimmune disease the -PI deems     │         │
│ them to be ineligible for)                         │ them to be ineligible for)                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Thyroid problems the PI deems them to be           │ Thyroid problems the PI deems them to be           │     100 │
│ ineligible for                                     │ ineligible for                                     │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Gout                                               │ Gout                                               │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Involved in another interventional study           │ Involved in another interventional study           │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Recent unintentional weight change (+/- 10 lbs. in │ Recent unintentional weight change (+/- 10 lbs. in │     100 │
│ the last 12 months)                                │ the last 12 months)                                │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Likely to not follow the protocol                  │ Likely to not follow the protocol                  │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ PI deems unfit to participate                      │ PI deems unfit to participate                      │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Already taking Metformin or any other drug         │ Already taking Metformin or any other drug         │     100 │
│ intended to treat diabetes                         │ intended to treat diabetes                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ eGFR \<45                                          │ eGFR <45                                           │      94 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ BMI \<18.5                                         │ BMI <18.5                                          │      95 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ MCI (MoCA \>18\<26 -inclusive of 1 point if \<12   │ MCI (MoCA >18<26 -inclusive of 1 point if <12      │      98 │
│ years of education Group 2                         │ years of education Group 2                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Decline physical function (walking speed \< 1 m/s) │ Decline physical function (walking speed < 1 m/s)  │      99 │
│ Group 3 (Either or both)                           │ Group 3 (Either or both)                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Abdominal obesity (\>88cm women, \>102cm men) AND  │ Abdominal obesity (>88cm women, >102cm men) AND    │      99 │
│ hypertension (treated or resting blood pressure    │ hypertension (treated or resting blood pressure    │         │
│ \>140/90                                           │ >140/90                                            │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Abdominal obesity (\>88cm women, \>102cm men) AND  │ Abdominal obesity (>88cm women, >102cm men) AND    │      99 │
│ hyperlipidemia (treated or fasting total           │ hyperlipidemia (treated or fasting total           │         │
│ cholesterol \>240 English literacy Willing to      │ cholesterol >240 English literacy Willing to       │         │
│ provide informed consent                           │ provide informed consent                           │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Type 2 diabetes (HbA1c\>6.5) or type 1 diabetes    │ Type 2 diabetes (HbA1c>6.5) or type 1 diabetes     │      99 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Low vitamin B12 Levels (\< 300 pg/mL)              │ Low vitamin B12 Levels (< 300 pg/mL)               │      99 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Excessive alcohol use (\>14 drinks/week)           │ Excessive alcohol use (>14 drinks/week)            │      99 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Dementia - diagnosed and/or MoCA score \<18        │ Dementia - diagnosed and/or MoCA score <18         │      99 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Hemoglobin \<8 or diagnosed with anemia            │ Hemoglobin <8 or diagnosed with anemia             │      99 │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════════════════════╤═══════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                 │ CHIA Criteria                                     │   Score │
╞═══════════════════════════════════════════════════╪═══════════════════════════════════════════════════╪═════════╡
│ Group 1 (Can have 1 or 2 of these, but not all 3) │ Cancer, with no active treatment in the last year │      39 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Must meet criteria from one or more of the        │ MCI (MoCA >18<26 -inclusive of 1 point if <12     │      40 │
│ following groups                                  │ years of education Group 2                        │         │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Must have minimum age of 65 Years                 │ End stage renal disease or on dialysis            │      42 │
├───────────────────────────────────────────────────┼───────────────────────────────────────────────────┼─────────┤
│ Must have maximum age of 79 Years                 │ End stage renal disease or on dialysis            │      42 │
╘═══════════════════════════════════════════════════╧═══════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 94
Average Levenshtein Ratio of individual lines: 92.18181818181819
OverAll Ratio: 93.0909090909091
